Modern Cancer Therapies and Traditional Medicine: an integrative approach to combat cancers.
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Singapore :
Bentham Science Publishers,
2021.
|
Schlagworte: | |
Online-Zugang: | Volltext |
Beschreibung: | Description based upon print version of record. The Two Major Classes of Targeted Therapy: Small Molecules and Monoclonal Antibodies (mAbs/MAbs). |
Beschreibung: | 1 online resource (352 p.) |
ISBN: | 9814998664 9789814998666 |
Internformat
MARC
LEADER | 00000cam a2200000Mu 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-on1290023355 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 211225s2021 si o ||| 0 eng d | ||
040 | |a EBLCP |b eng |c EBLCP |d EBLCP |d N$T |d OCLCF |d OCLCO |d OCLCL |d OCLCQ | ||
066 | |c (S | ||
019 | |a 1289370690 | ||
020 | |a 9814998664 | ||
020 | |a 9789814998666 |q (electronic bk.) | ||
035 | |a (OCoLC)1290023355 |z (OCoLC)1289370690 | ||
050 | 4 | |a R733 | |
082 | 7 | |a 615.5 |2 23/eng/20221202 | |
049 | |a MAIN | ||
245 | 0 | 0 | |a Modern Cancer Therapies and Traditional Medicine |h [electronic resource] : |b an integrative approach to combat cancers. |
260 | |a Singapore : |b Bentham Science Publishers, |c 2021. | ||
300 | |a 1 online resource (352 p.) | ||
500 | |a Description based upon print version of record. | ||
505 | 0 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- Dedication -- List of Contributors -- Evolution of Cancer Therapies -- Sonali Verma1, Gresh Chander1, Deepika Bhushan Raina1, Ruchi Shah2 and Rakesh Kumar1,* -- INTRODUCTION -- TARGETED CANCER THERAPIES -- Immunotherapy -- Antibody Therapy -- Interferons and Cytokines -- Cancer Vaccine Therapy -- Nanotechnology-Based Therapies -- Photodynamic Therapy -- Hyperthermia -- Role of Gene Therapy in Cancer Treatment -- Oncogene Silencing via RNAi -- Inhibitors of Signaling Cascades -- CONCLUSION | |
505 | 8 | |a Therapeutic Targets -- Vascular Endothelial Growth Factor Receptor Signaling (VEGF) -- Therapeutic Targets -- Toll-Like Receptors (TLRs) Pathway -- T-Cell Receptor (TCR) Pathway -- Hepatocyte Growth Factor (HGF) / Met Receptor Signaling -- c-Met as a Therapeutic Target -- Platelet-Derived Growth Factor (PDGF) Signaling -- Therapeutic Implications -- Epidermal Growth Factor Receptor (EGFR) Signaling Pathway -- Roles in Disease and Therapeutic Action -- Death Receptor (DR) Signaling -- Roles in Diseases -- TARGETED THERAPY -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST | |
505 | 8 | |a ACKNOWLEDGEMENTS -- REFERENCES -- Biomarkers for Cancer Therapy -- Indu Sharma1, Jyotsna Sharma2, Hemender Singh2 and Varun Sharma1,* -- INTRODUCTION -- DIFFERENT BIOMARKERS IN CANCERS -- DNA as a Biomarker -- RNAs as Biomarkers -- Proteins as Biomarkers -- BIOMARKERS AND PERSONALIZED MEDICINES -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Targeted Molecular Therapies in Cancer -- Prince Anand1,2,#, Sourabh Soni1,2,# and Yogendra S. Padwad1,2,* -- INTRODUCTION -- Contour of its Mechanism: The Way Targeted Therapies Works | |
505 | 8 | |a Hormone Therapy: Starve Cancer Cells of the Hormones It Needs To Grow -- Signal Transduction Inhibitors and Gene Expression Modulators: Stop Cancer Cells from Multiplying -- Apoptosis Inducers: Inducing Cell Death -- Angiogenesis Inhibitors: Inhibiting Stimuli that Help the Formation of New Blood Vessels in Tumors -- Immunotherapies: Aiding the Immune System of an Individual to Eliminate Cancer Cells -- LANDSCAPE OF TARGETED MOLECULAR THERAPIES: CLASSES, NOMENCLATURE, CATEGORIES, MODE OF ACTION AND CLINICAL SCENARIO | |
500 | |a The Two Major Classes of Targeted Therapy: Small Molecules and Monoclonal Antibodies (mAbs/MAbs). | ||
650 | 0 | |a Cancer |x Treatment. |0 http://id.loc.gov/authorities/subjects/sh85019547 | |
650 | 0 | |a Cancer |x Alternative treatment. |0 http://id.loc.gov/authorities/subjects/sh88002328 | |
650 | 0 | |a Integrative medicine. |0 http://id.loc.gov/authorities/subjects/sh2003001256 | |
650 | 0 | |a Evidence-based medicine. |0 http://id.loc.gov/authorities/subjects/sh97007984 | |
650 | 0 | |a Naturopathy. |0 http://id.loc.gov/authorities/subjects/sh85090300 | |
650 | 2 | |a Naturopathy |0 https://id.nlm.nih.gov/mesh/D009324 | |
650 | 6 | |a Cancer |x Traitement. | |
650 | 6 | |a Cancer |x Médecines parallèles. | |
650 | 6 | |a Médecine intégrative. | |
650 | 6 | |a Médecine factuelle. | |
650 | 6 | |a Naturopathie. | |
650 | 7 | |a Cancer |x Alternative treatment |2 fast | |
650 | 7 | |a Cancer |x Treatment |2 fast | |
650 | 7 | |a Evidence-based medicine |2 fast | |
650 | 7 | |a Integrative medicine |2 fast | |
650 | 7 | |a Naturopathy |2 fast | |
700 | 1 | |a Singh, Shashank K., |e editor. | |
700 | 1 | |a Singh, Reena, |e editor. | |
700 | 1 | |a Chopra, Chirag, |e editor. |0 http://id.loc.gov/authorities/names/n2021181113 | |
776 | 0 | 8 | |i Print version: |a Singh, Shashank K. |t Modern Cancer Therapies and Traditional Medicine:an Integrative Approach to Combat Cancers |d Singapore : Bentham Science Publishers,c2021 |z 9789814998673 |
856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3104708 |3 Volltext |
880 | 8 | |6 505-00/(S |a CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Signaling Pathways in Oncotherapy -- Sonia Thapa1,2, Arem Qayum1,2, Jasvinder Singh1,2, Tenzen Yodun1,2 and Shashank K. Singh1,2,* -- INTRODUCTION -- Extracellular Messengers -- MEMBRANE RECEPTORS -- G Protein-Coupled Receptors (GPCRs) and their Signaling -- Therapeutic Targets -- Fibroblast Growth Factor (FGF) Signaling Pathway -- Therapeutic Targets -- Insulin-Like Growth Factor Receptor (IGFR) Signaling Pathway -- Therapeutic Targets -- Transforming Growth Factor-β (TGF-β) Signaling Pathway | |
938 | |a ProQuest Ebook Central |b EBLB |n EBL6824835 | ||
938 | |a EBSCOhost |b EBSC |n 3104708 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-on1290023355 |
---|---|
_version_ | 1816882554523877376 |
adam_text | |
any_adam_object | |
author2 | Singh, Shashank K. Singh, Reena Chopra, Chirag |
author2_role | edt edt edt |
author2_variant | s k s sk sks r s rs c c cc |
author_GND | http://id.loc.gov/authorities/names/n2021181113 |
author_facet | Singh, Shashank K. Singh, Reena Chopra, Chirag |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | R - Medicine |
callnumber-label | R733 |
callnumber-raw | R733 |
callnumber-search | R733 |
callnumber-sort | R 3733 |
callnumber-subject | R - General Medicine |
collection | ZDB-4-EBA |
contents | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- Dedication -- List of Contributors -- Evolution of Cancer Therapies -- Sonali Verma1, Gresh Chander1, Deepika Bhushan Raina1, Ruchi Shah2 and Rakesh Kumar1,* -- INTRODUCTION -- TARGETED CANCER THERAPIES -- Immunotherapy -- Antibody Therapy -- Interferons and Cytokines -- Cancer Vaccine Therapy -- Nanotechnology-Based Therapies -- Photodynamic Therapy -- Hyperthermia -- Role of Gene Therapy in Cancer Treatment -- Oncogene Silencing via RNAi -- Inhibitors of Signaling Cascades -- CONCLUSION Therapeutic Targets -- Vascular Endothelial Growth Factor Receptor Signaling (VEGF) -- Therapeutic Targets -- Toll-Like Receptors (TLRs) Pathway -- T-Cell Receptor (TCR) Pathway -- Hepatocyte Growth Factor (HGF) / Met Receptor Signaling -- c-Met as a Therapeutic Target -- Platelet-Derived Growth Factor (PDGF) Signaling -- Therapeutic Implications -- Epidermal Growth Factor Receptor (EGFR) Signaling Pathway -- Roles in Disease and Therapeutic Action -- Death Receptor (DR) Signaling -- Roles in Diseases -- TARGETED THERAPY -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST ACKNOWLEDGEMENTS -- REFERENCES -- Biomarkers for Cancer Therapy -- Indu Sharma1, Jyotsna Sharma2, Hemender Singh2 and Varun Sharma1,* -- INTRODUCTION -- DIFFERENT BIOMARKERS IN CANCERS -- DNA as a Biomarker -- RNAs as Biomarkers -- Proteins as Biomarkers -- BIOMARKERS AND PERSONALIZED MEDICINES -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Targeted Molecular Therapies in Cancer -- Prince Anand1,2,#, Sourabh Soni1,2,# and Yogendra S. Padwad1,2,* -- INTRODUCTION -- Contour of its Mechanism: The Way Targeted Therapies Works Hormone Therapy: Starve Cancer Cells of the Hormones It Needs To Grow -- Signal Transduction Inhibitors and Gene Expression Modulators: Stop Cancer Cells from Multiplying -- Apoptosis Inducers: Inducing Cell Death -- Angiogenesis Inhibitors: Inhibiting Stimuli that Help the Formation of New Blood Vessels in Tumors -- Immunotherapies: Aiding the Immune System of an Individual to Eliminate Cancer Cells -- LANDSCAPE OF TARGETED MOLECULAR THERAPIES: CLASSES, NOMENCLATURE, CATEGORIES, MODE OF ACTION AND CLINICAL SCENARIO |
ctrlnum | (OCoLC)1290023355 |
dewey-full | 615.5 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.5 |
dewey-search | 615.5 |
dewey-sort | 3615.5 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05440cam a2200613Mu 4500</leader><controlfield tag="001">ZDB-4-EBA-on1290023355</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">211225s2021 si o ||| 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">EBLCP</subfield><subfield code="b">eng</subfield><subfield code="c">EBLCP</subfield><subfield code="d">EBLCP</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="066" ind1=" " ind2=" "><subfield code="c">(S</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1289370690</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9814998664</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789814998666</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1290023355</subfield><subfield code="z">(OCoLC)1289370690</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R733</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.5</subfield><subfield code="2">23/eng/20221202</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Modern Cancer Therapies and Traditional Medicine</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">an integrative approach to combat cancers.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Singapore :</subfield><subfield code="b">Bentham Science Publishers,</subfield><subfield code="c">2021.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (352 p.)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based upon print version of record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- Dedication -- List of Contributors -- Evolution of Cancer Therapies -- Sonali Verma1, Gresh Chander1, Deepika Bhushan Raina1, Ruchi Shah2 and Rakesh Kumar1,* -- INTRODUCTION -- TARGETED CANCER THERAPIES -- Immunotherapy -- Antibody Therapy -- Interferons and Cytokines -- Cancer Vaccine Therapy -- Nanotechnology-Based Therapies -- Photodynamic Therapy -- Hyperthermia -- Role of Gene Therapy in Cancer Treatment -- Oncogene Silencing via RNAi -- Inhibitors of Signaling Cascades -- CONCLUSION</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Therapeutic Targets -- Vascular Endothelial Growth Factor Receptor Signaling (VEGF) -- Therapeutic Targets -- Toll-Like Receptors (TLRs) Pathway -- T-Cell Receptor (TCR) Pathway -- Hepatocyte Growth Factor (HGF) / Met Receptor Signaling -- c-Met as a Therapeutic Target -- Platelet-Derived Growth Factor (PDGF) Signaling -- Therapeutic Implications -- Epidermal Growth Factor Receptor (EGFR) Signaling Pathway -- Roles in Disease and Therapeutic Action -- Death Receptor (DR) Signaling -- Roles in Diseases -- TARGETED THERAPY -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">ACKNOWLEDGEMENTS -- REFERENCES -- Biomarkers for Cancer Therapy -- Indu Sharma1, Jyotsna Sharma2, Hemender Singh2 and Varun Sharma1,* -- INTRODUCTION -- DIFFERENT BIOMARKERS IN CANCERS -- DNA as a Biomarker -- RNAs as Biomarkers -- Proteins as Biomarkers -- BIOMARKERS AND PERSONALIZED MEDICINES -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Targeted Molecular Therapies in Cancer -- Prince Anand1,2,#, Sourabh Soni1,2,# and Yogendra S. Padwad1,2,* -- INTRODUCTION -- Contour of its Mechanism: The Way Targeted Therapies Works</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Hormone Therapy: Starve Cancer Cells of the Hormones It Needs To Grow -- Signal Transduction Inhibitors and Gene Expression Modulators: Stop Cancer Cells from Multiplying -- Apoptosis Inducers: Inducing Cell Death -- Angiogenesis Inhibitors: Inhibiting Stimuli that Help the Formation of New Blood Vessels in Tumors -- Immunotherapies: Aiding the Immune System of an Individual to Eliminate Cancer Cells -- LANDSCAPE OF TARGETED MOLECULAR THERAPIES: CLASSES, NOMENCLATURE, CATEGORIES, MODE OF ACTION AND CLINICAL SCENARIO</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">The Two Major Classes of Targeted Therapy: Small Molecules and Monoclonal Antibodies (mAbs/MAbs).</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Treatment.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85019547</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Alternative treatment.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh88002328</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Integrative medicine.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh2003001256</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Evidence-based medicine.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh97007984</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Naturopathy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85090300</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Naturopathy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D009324</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Traitement.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Médecines parallèles.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médecine intégrative.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médecine factuelle.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Naturopathie.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Alternative treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Evidence-based medicine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Integrative medicine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Naturopathy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Singh, Shashank K.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Singh, Reena,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chopra, Chirag,</subfield><subfield code="e">editor.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2021181113</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Singh, Shashank K.</subfield><subfield code="t">Modern Cancer Therapies and Traditional Medicine:an Integrative Approach to Combat Cancers</subfield><subfield code="d">Singapore : Bentham Science Publishers,c2021</subfield><subfield code="z">9789814998673</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3104708</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="880" ind1="8" ind2=" "><subfield code="6">505-00/(S</subfield><subfield code="a">CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Signaling Pathways in Oncotherapy -- Sonia Thapa1,2, Arem Qayum1,2, Jasvinder Singh1,2, Tenzen Yodun1,2 and Shashank K. Singh1,2,* -- INTRODUCTION -- Extracellular Messengers -- MEMBRANE RECEPTORS -- G Protein-Coupled Receptors (GPCRs) and their Signaling -- Therapeutic Targets -- Fibroblast Growth Factor (FGF) Signaling Pathway -- Therapeutic Targets -- Insulin-Like Growth Factor Receptor (IGFR) Signaling Pathway -- Therapeutic Targets -- Transforming Growth Factor-β (TGF-β) Signaling Pathway</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL6824835</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3104708</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-4-EBA-on1290023355 |
illustrated | Not Illustrated |
indexdate | 2024-11-27T13:30:28Z |
institution | BVB |
isbn | 9814998664 9789814998666 |
language | English |
oclc_num | 1290023355 |
open_access_boolean | |
owner | MAIN DE-863 DE-BY-FWS |
owner_facet | MAIN DE-863 DE-BY-FWS |
physical | 1 online resource (352 p.) |
psigel | ZDB-4-EBA |
publishDate | 2021 |
publishDateSearch | 2021 |
publishDateSort | 2021 |
publisher | Bentham Science Publishers, |
record_format | marc |
spelling | Modern Cancer Therapies and Traditional Medicine [electronic resource] : an integrative approach to combat cancers. Singapore : Bentham Science Publishers, 2021. 1 online resource (352 p.) Description based upon print version of record. Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- Dedication -- List of Contributors -- Evolution of Cancer Therapies -- Sonali Verma1, Gresh Chander1, Deepika Bhushan Raina1, Ruchi Shah2 and Rakesh Kumar1,* -- INTRODUCTION -- TARGETED CANCER THERAPIES -- Immunotherapy -- Antibody Therapy -- Interferons and Cytokines -- Cancer Vaccine Therapy -- Nanotechnology-Based Therapies -- Photodynamic Therapy -- Hyperthermia -- Role of Gene Therapy in Cancer Treatment -- Oncogene Silencing via RNAi -- Inhibitors of Signaling Cascades -- CONCLUSION Therapeutic Targets -- Vascular Endothelial Growth Factor Receptor Signaling (VEGF) -- Therapeutic Targets -- Toll-Like Receptors (TLRs) Pathway -- T-Cell Receptor (TCR) Pathway -- Hepatocyte Growth Factor (HGF) / Met Receptor Signaling -- c-Met as a Therapeutic Target -- Platelet-Derived Growth Factor (PDGF) Signaling -- Therapeutic Implications -- Epidermal Growth Factor Receptor (EGFR) Signaling Pathway -- Roles in Disease and Therapeutic Action -- Death Receptor (DR) Signaling -- Roles in Diseases -- TARGETED THERAPY -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST ACKNOWLEDGEMENTS -- REFERENCES -- Biomarkers for Cancer Therapy -- Indu Sharma1, Jyotsna Sharma2, Hemender Singh2 and Varun Sharma1,* -- INTRODUCTION -- DIFFERENT BIOMARKERS IN CANCERS -- DNA as a Biomarker -- RNAs as Biomarkers -- Proteins as Biomarkers -- BIOMARKERS AND PERSONALIZED MEDICINES -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Targeted Molecular Therapies in Cancer -- Prince Anand1,2,#, Sourabh Soni1,2,# and Yogendra S. Padwad1,2,* -- INTRODUCTION -- Contour of its Mechanism: The Way Targeted Therapies Works Hormone Therapy: Starve Cancer Cells of the Hormones It Needs To Grow -- Signal Transduction Inhibitors and Gene Expression Modulators: Stop Cancer Cells from Multiplying -- Apoptosis Inducers: Inducing Cell Death -- Angiogenesis Inhibitors: Inhibiting Stimuli that Help the Formation of New Blood Vessels in Tumors -- Immunotherapies: Aiding the Immune System of an Individual to Eliminate Cancer Cells -- LANDSCAPE OF TARGETED MOLECULAR THERAPIES: CLASSES, NOMENCLATURE, CATEGORIES, MODE OF ACTION AND CLINICAL SCENARIO The Two Major Classes of Targeted Therapy: Small Molecules and Monoclonal Antibodies (mAbs/MAbs). Cancer Treatment. http://id.loc.gov/authorities/subjects/sh85019547 Cancer Alternative treatment. http://id.loc.gov/authorities/subjects/sh88002328 Integrative medicine. http://id.loc.gov/authorities/subjects/sh2003001256 Evidence-based medicine. http://id.loc.gov/authorities/subjects/sh97007984 Naturopathy. http://id.loc.gov/authorities/subjects/sh85090300 Naturopathy https://id.nlm.nih.gov/mesh/D009324 Cancer Traitement. Cancer Médecines parallèles. Médecine intégrative. Médecine factuelle. Naturopathie. Cancer Alternative treatment fast Cancer Treatment fast Evidence-based medicine fast Integrative medicine fast Naturopathy fast Singh, Shashank K., editor. Singh, Reena, editor. Chopra, Chirag, editor. http://id.loc.gov/authorities/names/n2021181113 Print version: Singh, Shashank K. Modern Cancer Therapies and Traditional Medicine:an Integrative Approach to Combat Cancers Singapore : Bentham Science Publishers,c2021 9789814998673 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3104708 Volltext 505-00/(S CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Signaling Pathways in Oncotherapy -- Sonia Thapa1,2, Arem Qayum1,2, Jasvinder Singh1,2, Tenzen Yodun1,2 and Shashank K. Singh1,2,* -- INTRODUCTION -- Extracellular Messengers -- MEMBRANE RECEPTORS -- G Protein-Coupled Receptors (GPCRs) and their Signaling -- Therapeutic Targets -- Fibroblast Growth Factor (FGF) Signaling Pathway -- Therapeutic Targets -- Insulin-Like Growth Factor Receptor (IGFR) Signaling Pathway -- Therapeutic Targets -- Transforming Growth Factor-β (TGF-β) Signaling Pathway |
spellingShingle | Modern Cancer Therapies and Traditional Medicine an integrative approach to combat cancers. Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- Dedication -- List of Contributors -- Evolution of Cancer Therapies -- Sonali Verma1, Gresh Chander1, Deepika Bhushan Raina1, Ruchi Shah2 and Rakesh Kumar1,* -- INTRODUCTION -- TARGETED CANCER THERAPIES -- Immunotherapy -- Antibody Therapy -- Interferons and Cytokines -- Cancer Vaccine Therapy -- Nanotechnology-Based Therapies -- Photodynamic Therapy -- Hyperthermia -- Role of Gene Therapy in Cancer Treatment -- Oncogene Silencing via RNAi -- Inhibitors of Signaling Cascades -- CONCLUSION Therapeutic Targets -- Vascular Endothelial Growth Factor Receptor Signaling (VEGF) -- Therapeutic Targets -- Toll-Like Receptors (TLRs) Pathway -- T-Cell Receptor (TCR) Pathway -- Hepatocyte Growth Factor (HGF) / Met Receptor Signaling -- c-Met as a Therapeutic Target -- Platelet-Derived Growth Factor (PDGF) Signaling -- Therapeutic Implications -- Epidermal Growth Factor Receptor (EGFR) Signaling Pathway -- Roles in Disease and Therapeutic Action -- Death Receptor (DR) Signaling -- Roles in Diseases -- TARGETED THERAPY -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST ACKNOWLEDGEMENTS -- REFERENCES -- Biomarkers for Cancer Therapy -- Indu Sharma1, Jyotsna Sharma2, Hemender Singh2 and Varun Sharma1,* -- INTRODUCTION -- DIFFERENT BIOMARKERS IN CANCERS -- DNA as a Biomarker -- RNAs as Biomarkers -- Proteins as Biomarkers -- BIOMARKERS AND PERSONALIZED MEDICINES -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Targeted Molecular Therapies in Cancer -- Prince Anand1,2,#, Sourabh Soni1,2,# and Yogendra S. Padwad1,2,* -- INTRODUCTION -- Contour of its Mechanism: The Way Targeted Therapies Works Hormone Therapy: Starve Cancer Cells of the Hormones It Needs To Grow -- Signal Transduction Inhibitors and Gene Expression Modulators: Stop Cancer Cells from Multiplying -- Apoptosis Inducers: Inducing Cell Death -- Angiogenesis Inhibitors: Inhibiting Stimuli that Help the Formation of New Blood Vessels in Tumors -- Immunotherapies: Aiding the Immune System of an Individual to Eliminate Cancer Cells -- LANDSCAPE OF TARGETED MOLECULAR THERAPIES: CLASSES, NOMENCLATURE, CATEGORIES, MODE OF ACTION AND CLINICAL SCENARIO Cancer Treatment. http://id.loc.gov/authorities/subjects/sh85019547 Cancer Alternative treatment. http://id.loc.gov/authorities/subjects/sh88002328 Integrative medicine. http://id.loc.gov/authorities/subjects/sh2003001256 Evidence-based medicine. http://id.loc.gov/authorities/subjects/sh97007984 Naturopathy. http://id.loc.gov/authorities/subjects/sh85090300 Naturopathy https://id.nlm.nih.gov/mesh/D009324 Cancer Traitement. Cancer Médecines parallèles. Médecine intégrative. Médecine factuelle. Naturopathie. Cancer Alternative treatment fast Cancer Treatment fast Evidence-based medicine fast Integrative medicine fast Naturopathy fast |
subject_GND | http://id.loc.gov/authorities/subjects/sh85019547 http://id.loc.gov/authorities/subjects/sh88002328 http://id.loc.gov/authorities/subjects/sh2003001256 http://id.loc.gov/authorities/subjects/sh97007984 http://id.loc.gov/authorities/subjects/sh85090300 https://id.nlm.nih.gov/mesh/D009324 |
title | Modern Cancer Therapies and Traditional Medicine an integrative approach to combat cancers. |
title_auth | Modern Cancer Therapies and Traditional Medicine an integrative approach to combat cancers. |
title_exact_search | Modern Cancer Therapies and Traditional Medicine an integrative approach to combat cancers. |
title_full | Modern Cancer Therapies and Traditional Medicine [electronic resource] : an integrative approach to combat cancers. |
title_fullStr | Modern Cancer Therapies and Traditional Medicine [electronic resource] : an integrative approach to combat cancers. |
title_full_unstemmed | Modern Cancer Therapies and Traditional Medicine [electronic resource] : an integrative approach to combat cancers. |
title_short | Modern Cancer Therapies and Traditional Medicine |
title_sort | modern cancer therapies and traditional medicine an integrative approach to combat cancers |
title_sub | an integrative approach to combat cancers. |
topic | Cancer Treatment. http://id.loc.gov/authorities/subjects/sh85019547 Cancer Alternative treatment. http://id.loc.gov/authorities/subjects/sh88002328 Integrative medicine. http://id.loc.gov/authorities/subjects/sh2003001256 Evidence-based medicine. http://id.loc.gov/authorities/subjects/sh97007984 Naturopathy. http://id.loc.gov/authorities/subjects/sh85090300 Naturopathy https://id.nlm.nih.gov/mesh/D009324 Cancer Traitement. Cancer Médecines parallèles. Médecine intégrative. Médecine factuelle. Naturopathie. Cancer Alternative treatment fast Cancer Treatment fast Evidence-based medicine fast Integrative medicine fast Naturopathy fast |
topic_facet | Cancer Treatment. Cancer Alternative treatment. Integrative medicine. Evidence-based medicine. Naturopathy. Naturopathy Cancer Traitement. Cancer Médecines parallèles. Médecine intégrative. Médecine factuelle. Naturopathie. Cancer Alternative treatment Cancer Treatment Evidence-based medicine Integrative medicine |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3104708 |
work_keys_str_mv | AT singhshashankk moderncancertherapiesandtraditionalmedicineanintegrativeapproachtocombatcancers AT singhreena moderncancertherapiesandtraditionalmedicineanintegrativeapproachtocombatcancers AT choprachirag moderncancertherapiesandtraditionalmedicineanintegrativeapproachtocombatcancers |